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The collagen prolyl 4-hydroxylases (P4Hs) are
essential for proper extracellular matrix
formation in multicellular organisms. The
vertebrate enzymes are ?2?2 tetramers, in
which the ? subunits are identical to protein
disulfide isomerase (PDI). Unique P4H forms
have been shown to assemble from the
Caenorhabditis elegans catalytic ?  subunit
isoforms PHY-1 and PHY-2 and the ? subunit
PDI-2. A mixed PHY-1/PHY-2/(PDI-2)2
tetramer is the major form, while PHY-1/PDI-
2 and PHY-2/PDI-2 dimers are also assembled
but less efficiently.  Cloning and
characterization of the orthologous subunits
from the closely related nematode
Caenorhabditis briggsae revealed distinct
differences in the assembly of active P4H
forms in spite of the extremely high amino
acid sequence identity (92-97%) between the
C. briggsae  and C. elegans subunits. In
addition to a PHY-1/PHY-2(PDI-2)2 tetramer
and a PHY-1/PDI-2 dimer, an active (PHY-
2)2(PDI-2)2 tetramer was formed in C .
briggsae instead of a PHY-2/PDI-2 dimer.
Site-directed mutagenesis studies and
generation of inter-species hybrid polypeptides
showed that the N-terminal halves of the
C a e n o r h a b d i t i s  PHY-2 polypeptides
determine their assembly properties. Genetic
disruption of C. briggsae phy-1 (Cb-dpy-18)
via a Mos1 insertion resulted a small (short)
phenotype that is less severe than the dumpy
(short and fat) phenotype of the corresponding
C. elegans mutants (Ce-dpy-18). C. briggsae
phy-2 RNA interference produced no visible
phenotype in the wild type nematodes but
produced a severe dumpy phenotype and larval
a r res t  in  p h y - 1  mutants. G e n e t i c
complementation of the C. briggsae and C.
elegans phy-1 mutants was achieved by
injection of a wild type phy-1 gene from either
species.
Introduction
The collagen prolyl 4-hydroxylases
(P4Hs) are endoplasmic reticulum (ER)
lumenal enzymes that hydroxylate prolines in -
X-Pro-Gly- triplets of collagen chains (1-3).
This essential reaction requires Fe2+, 2-
oxoglutarate, oxygen and ascorbate, and
precedes the folding of the polypeptide chains
into stable triple-helical collagen molecules.
Collagen P4Hs are ? 2?2 tetramers in
vertebrates, the ?  subunits of which
correspond to the enzyme and chaperone
protein disulfide isomerase (PDI). These
PDI/? subunits are required to maintain the ?
subunits in an active, soluble conformation
and for retaining the tetramer within the ER.
The ? subunit contains the catalytic site with
conserved residues required for the binding of
the Fe2+ and 2-oxoglutarate (4, 5) and the
peptide-substrate-binding domain (6, 7). Three
? subunit isoforms have been characterized
from human and mouse that assemble into
[?(I)]2?2, [? (II)]2?2 and [?(III)]2?2 tetramers
(8-12) and display distinct tissue distributions
(11, 13, 14). The Drosophila melanogaster
genome contains about 20 genes encoding
collagen P4H ? subunit-like polypeptides, the
one characterized in detail also assembling
into an active ?2?2 tetramer (15, 16).
The nematode Caenorhabditis elegans has
two conserved genes encoding collagen P4H ?
subunits, named phy-1 (also known as dpy-18)
and phy-2 that are involved in the synthesis of
cuticle collagens (17-20). Based on in vivo and
in vitro studies these subunits assemble into
unique collagen P4H forms with a ? subunit
encoded by the pdi-2 gene (17, 21-23). The
main collagen P4H form in C. elegans is a
2PHY-1/PHY-2/(PDI-2)2 tetramer, but a PHY-
1/PDI-2 dimer and a PHY-2/PDI-2 dimer can
also be assembled albeit at a much lower
efficiency (20-22). A collagen P4H tetramer
containing two different catalytically active
subunits has not been found in any other
organism, and insect cell co-expression studies
have shown that the human ?(I) and ?(II)
subunits do not assemble into mixed tetramers
of this type (10). Formation of the C. elegans
mixed tetramer is species-specific as the C.
elegans PHY-1, PHY-2 or PDI-2 could not be
replaced in insect cell coexpression
experiments by a recombinant collagen P4H ?
or ? subunit from human or Drosophila (20).
Detailed studies with hybrid recombinant
PHY-1/PHY-2 polypeptides revealed that
PHY-1 residues Gln121-Ala271 and PHY-2
residues Asp1-Leu122 are essential for the
assembly of the mixed tetramer (20).
The C. elegans phy-1, phy-2  and pdi-2
genes are expressed in the hypodermis (17,
20), a tissue whose main role is to secrete the
collagenous exoskeleton known as the cuticle
(23). All three genes are expressed temporally
in a cyclical pattern that matches the
expression of the exoskeleton collagens,
namely the molting cycle (17). In agreement
with the assembly properties of these subunits,
mutations in their genes result in distinct
phenotypes. The phy-1 null mutant (dpy-18) is
dumpy (short and fat) with a defective
exoskeleton (17-19). The loss of the PHY-
1/PHY-2/(PDI-2)2 and PHY-1/PDI-2 forms in
these mutants can be partially compensated by
assembly of the PHY-2/PDI-2 dimer, which is
not detected in the wild type nematodes (20).
In contrast, the phy-2 null mutants are wild
type in appearance, an attribute that is a direct
consequence of the PHY-1/PDI-2 dimer, the
formation of which becomes highly up-
regulated in this mutant strain (20). A phy-2
RNA interference (RNAi) knockdown in the
dpy-18 mutant background leads to loss of all
collagen P4H forms and the resultant
nematode embryos fail to hatch. These
embryos die at the point where the exoskeleton
usually assumes the role of maintaining the
body shape, thereby confirming an essential
function for both PHY-1 and PHY-2 in the
synthesis of a proper collagenous cuticle (17).
Two additional genes encoding collagen P4H
?  subunit-like polypeptides exist in the C .
elegans genome but are not involved in the
synthesis of cuticle collagens (24); (Keskiaho
et al unpublished).
The unusual collagen P4H forms
assembled by the C. elegans PHY-1, PHY-2
and PDI-2 polypeptides and their important
roles in the establishment of the collagenous
exoskeleton led us to examine the orthologous
genes in the closely related free-living
bacterivorous soil nematodes C. elegans and
Caenorhabditis briggsae. Complete genome
sequences are available for both species
allowing detailed comparative genome
analysis (25). We report here the cloning of
the collagen P4H subunit orthologues in C.
briggsae , their biochemical and genetic
characterization, and relate these results to the
C. elegans data. Surprisingly, despite the high
identity at the amino acid level, some of the
assembly properties of the C. briggsae
collagen P4H ? subunits were found to differ
distinctly from those of C. elegans. In addition
to the PHY-1/PHY-2/(PDI-2)2 tetramers and
PHY-1/PDI-2 dimers formed in both species,
C. briggsae PHY-2 readily associated with
PDI-2 to form an active (PHY-2)2/(PDI-2)2
tetramer, which is not found in C. elegans.
This allowed us to identify regions and
individual amino acids in PHY-1 and PHY-2
that are important in the assembly of the
different enzyme forms. We also studied the in
vivo roles of the C. briggsae collagen P4H
subunits in the formation of the cuticle by
RNA interference and through the generation
of a Mos1 Cb-dpy-18  mutant, and by
examining the ability of the C. elegans and C.
briggsae PHY polypeptides to rescue the dpy-
18 phenotype in both species.
Experimental Procedures
Nematode Strains and Generation of C.
briggsae dpy-18 Mutant - The C. elegans
strains N2 (wild type), CB364 (dpy-18 e364)
and dpy-18 e1096, and the C. briggsae strain
AF16 (wild type) were received from the
Caenorhabditis Genetics Center. To generate
the Cb-dpy-18 mutant strain, mutagenesis
using the heterologous D r o s o p h i l a  Mos1
transposon was performed in C. briggsae
basically as previously described for C.
elegans (26, 27). A marked transgenic strain
bearing the M o s 1  transposon, JU826
(mfEx24[pPD9; Ce-myo-3::GFP]) ,  was
obtained by injection of C. briggsae AF16
with 10µg/ml pPD9 (Mos1) and 100 µg/ml
pPD93.97 (Ce-myo-3::GFP ). A marked
transgenic strain bearing the Mos1 transposase
under a heat-shock promoter, JU786
(mfEx18[pJL44.2; Ce-myo-2::GFP]), was
obtained by injection with 90 mg/µl pJL44.2
(Ce-hsp16.48::GFP::glh-2 3?U T R ) and 10
3µg/ml pPD118.33 (Ce-myo-2::GFP). For
mutagenesis, males bearing mfEx18 were
crossed to hermaphrodites bearing mfEx24 and
double transgenics were amplified for two
generations. Double transgenic adults were
then heat-shocked (2h40 at 37°C, 35 min at
20°C, 60 min at 37°C and overnight at 25°C).
Mos1 insertion efficiency was monitored by
isolating random F1 progeny and non-Myo-
3::GFP F2 and F3 progeny and scoring the
latter by PCR for transposon presence using
oligonucleotides oJL102 and oJL103, and for
mfEx24 absence using oJL103 and oJL104
(26). Three out of 46 random F1 animals had a
Mos1 insertion. The mf104 mutation was
found by visual inspection of the F2 progeny
and was outcrossed five times to the wild type
AF16 strain, yielding strain JU929. Using
inverse PCR and BLAST on the C. briggsae
genome in Wormbase, the mf104 Mos1
insertion was found to be located at the very
end of exon 4 of Cb-phy-1  (CBG13195),
b e f o r e  t h e  s e q u e n c e
TATgtgagtcgatttgtttgatcgg.
Cloning of C. briggsae Collagen P4H
Subunits and Generation of Recombinant
Baculoviruses - Putative genes encoding C.
b r i g g s a e  collagen P4H subunits were
identified by homology to the C. elegans phy-
1, phy-2 and pdi-2 genes from sequence data
generated by the C. briggsae genome sequence
project (http://www.wormbase.org/db/seq
gbrowse/briggsae/). The cDNAs were cloned
and sequenced from mRNA derived from a
mixed stage culture of wild type C. briggsae
nematodes using Trizol reagent (Invitrogen)
and a StrataScript cDNA Synthesis kit
(Stratagene). The following cloning primers
were used (restriction sites underlined):
C b p h y 1 F o r  ( N o t I)  5 ? -
cgcgcggccgcATGCGTCTAGCACTTCTTGT
G C T G - 3 ? ,  Cbphy1Rev (XbaI) 5 ? -
gcgtctagaTTAAATGGTCTCCCAAACATCT
T T T C - 3 ? ,  Cbphy2For (NotI) 5 ? -
gcggcggccgcATGAGAACAGTAGCGATTG
T C T G C - 3 ?, Cbphy2Rev (XbaI) 5 ? -
gcgtctagaCTATGGATCGTTGGCGTATGGA
GAC-3?,  C b p d i 2 F o r  (N o t I )  5?-
gcggcggccgcATGTTCCGGCTCGTCGGTCT
G - 3 ? ,  C b p d i 2 R e v  ( X b a I )  5 ? -
gcgtctagaTTAGAGCTCAGTGTGTCCCTC-
3 ?. The products were cloned into the
pVL1392 baculovirus expression vector
(Pharmingen).
For the expression of hybrid PHY-2
polypeptides in insect cells constructs were
generated in which sequences coding for the
N- and C-terminal halves were swapped
between the Caenorhabditis species. A cDNA
fragment encoding the N-terminal half of Ce-
phy-2 was amplified by PCR using the primers
C e p h y 2 B V F  (N o t I )  5?-
gacgcggccgcATGAGAGCAGTTTTGCTAGT
C - 3 ?  and  Cephy2N- te rmR 5 ? -
TCAACAATTCCATCGTACTC-3? and that
encoding the C-terminal half using the primers
C e p h y 2 C - t e r m F  5 ? -
GAGAGATGCATATGAAGC-3? a n d
p h y 2 B V R  ( X b a I )  5?-
gcgtctagaCTATGGATCATTGGCATATGGG
GAC-3?, and the plasmid pVL1392Cephy2
(20)  as a template. A cDNA fragment
encoding the N-terminal half of Cb-phy-2 was
generated using primers Cbphy2For (NotI)
(see above) and Cbphy2N-termR 5?-
TCAACGATTCCATCGAATTC-3?, and that
encoding the C-terminal half using primers
C b p h y 2 C - t e r m F  5 ? -
A A G A G A C G C T T A T G A G G C - 3 ? and
Cbphy2R (XbaI) (see above), and the
pVL1392Cbphy2 (see above) as a template.
The amplified fragments were co-ligated into
NotI-XbaI digested pVL1392 and named
pVL1392-CeN/CbCphy-2 and pVL1392-
CbN/CeCphy-2.
Site-directed mutagenesis was carried out
using the QuikChange Kit (Stratagene)
f o l l o w i n g  t h e  m a n u f a c t u r e r s
recommendations. The single mutants Ce-phy-
1 T220A, Cb-phy-1 A220T, Ce-phy-2 W190S
and Cb-phy-2 S190W (numbers of the amino
acid positions refer to mature protein
sequences after cleavage of the signal
peptides) were generated in the first
mutagenesis round using complementary sense
and antisense mutagenic primers (the sense
primers are shown, the bases introducing the
desired mutation are underlined): Ce-phy-1
T 2 2 0 A  5 ? -
CTCTACAAAATGAACCCAGCTCACCCA
CGCGCCAAAG-3 ?, Ce-phy-2 W190S 5?-
CACCAACAATTGAGGAATCGGAAATTC
T C G A G T A T C - 3 ?, Cb-phy-1 A220T 5?-
GTTGTACAAAATGAACCCAACTCATCC
ACGTGCCAAAG-3?, Cb-phy-2 S190W 5?-
CCACCAAGTGTCGAAGAATGGGAAATC
C T T G A A T A T C T G G - 3 ?. The plasmids
pVL1392Cephy1 (21), pVL1392Cephy2 (20),
and pVL1392Cbphy1 and pVL1392Cbphy2
described above were used as templates in the
mutagenesis reactions. The double mutants
Ce-phy-1 Q174K/T220A, Cb-phy-1
K174Q/A220T, Ce-phy-2 V177N/W190S and
4Cb-phy-2 N177V/S190W were generated
similarly in the second mutagenesis round
using complementary sense and antisense
mutagenic primers (the sense primers are
s h o w n ) :  C e - p h y - 1  Q 1 7 4 K  5 ? -
GTGGATGGAGGAGGCGAAGAGAAGAC
T C G G C G A C - 3 ?, Ce-phy-2 V177N 5?-
GATGCAGGTTGCGTTGAATAAGATCGA
AAACGAG-3?,  Cb-phy-1 K174Q 5 ? -
GTGGATGGAAGAGGCTCAGAGAAGAA
T G G A T G A T G - 3 ?, Cb-phy-2 N177V 5?-
GATGCAAGTTGCTTTGGTCAAAATCGA
GAACGAG-3? and the plasmids derived from
the first round of mutagenesis as templates.
The recombinant baculovirus constructs
were co-transfected into S p o d o p t e r a
f r u g i p e r d a  Sf9 cells with a modified
Autographa californica nuclear polyhedrosis
virus DNA using the BaculoGold transfection
kit (Pharmingen) and the resultant virus pools
were collected and amplified (28).
Expression and Analysis of Recombinant
Proteins in Insect Cells - Insect cells (Sf9,
Invitrogen) were cultured in TNM-FH medium
(Sigma) supplemented with 10% insect cell
qualified fetal bovine serum (Gibco) as
monolayers at 27°C. Cells seeded at a density
of 5x106 per 100-mm plate were infected at a
multiplicity of five with different
combinations of the viruses. The cells were
harvested 72 h after infection, washed with a
solution of 0.15 M NaCl and 0.02 M
phosphate, pH 7.4, homogenized in a solution
of 0.1 M glycine, 0.1 M NaCl, 10 ?M
dithiothreitol, 0.1% Triton X-100, and 0.01 M
Tris, pH 7.8, and centrifuged at 10,000 x g for
20 min. Samples of the resulting supernatants
were analyzed by 8% SDS-PAGE under
reducing conditions or 8% nondenaturating
PAGE followed by Western blotting and
assayed for enzyme activity by a method based
on the hydroxylation-coupled decarboxylation
of 2-oxo[1-14C]glutarate (29).
The molecular weight of the P4H
assembled from C. briggsae PHY-2 and PDI-2
was analyzed by applying the Triton X-100-
soluble fraction of insect cells coexpressing
these recombinant polypeptides to a calibrated
HiPrep Sephacryl S-200 HR gel filtration
column (Amersham Biosciences), equilibrated
and eluted with 0.1 M NaCl, 0.1 M glycine, 10
µM dithiothreitol, and 0.01 M Tris buffer, pH
7.4, and P4H activity was assayed in the eluted
fractions. Triton X-100 extracts from insect
cells coexpressing C. elegans PHY-1 and
human PDI and purified recombinant human
collagen P4H-I (30) were used as controls in
gel filtration experiments.
Antibodies - The polyclonal antibodies
used in the study were generated against
synthetic peptides representing the C-termini
of the C. elegans PHY-1, PHY-2 and PDI-2
(20). The amino acid sequences of these
peptide antigens are highly conserved in the
corresponding C. briggsae polypeptides and
the antibodies recognize the orthologous
subunits in both species. Western blot analysis
of baculovirus-generated recombinant proteins
was performed by transferring samples from
non-denaturing PAGE to an Immobilon-P
membrane (Millipore), followed by incubation
with the antibodies described above and a
subsequent incubation with an alkaline
phosphatase-conjugated secondary antibody
(Sigma).
Characterization of Collagen P4Hs from
Nematode Lysates - Native worm extracts
were prepared by extraction from mixed stage
nematodes as described previously (20) and
the proteins were analyzed by 8% non-
denaturing PAGE followed by Western
blotting as described above.
Rescue of the dpy-18 Mutants - Cb-phy-1
and Cb-phy-2 rescue constructs were amplified
from wild type C. briggsae genomic DNA
(2416 and 3384 bp respectively) using Pfu
Turbo DNA Polymerase (Stratagene) and the
following primers: Cbphy1ResF (XbaI) 5?-
gctctagaGATGCGTCTAGCACTTCTTGTGC
TGGCA-3?,  Cbphy1ResR (SacII) 5?-
gaccgcggTTAAATGGTCTCCCAAACATCT
T T T C C - 3 ? , Cbphy2ResF (XbaI) 5?-
gctctagaGATGAGAACAGTAGCGATTGTC
TGC-3?,  Cbphy2ResR (SacI I )  5?-
gaccgcggCTATGGATCGTTGGCGTATGGA
GAC-3?. A C. elegans phy-2 rescue construct
was generated by PCR (4775bp) from C.
elegans N2 genomic DNA using the following
p r imer s :  phy -2FLF  (Xba I )  5 ? -
gctctagaGATGAGAGCAGTTTTGCTAGTC-
3 ? ,  p h y - 2 F L R  ( S a c I I )  5 ? -
gaccgcggCTATGGATCATTGGCATATG-3?.
All products were cloned into the vector
pAW1 (31), that contains 2760 bp of the C.
elegans phy1 promoter and 205 bp of the 3?
untranslated region, via the cloning vector
pCRScript (Stratagene). Generation of the
genomic C. elegans phy-1 rescue construct has
been described previously (17). Rescue
constructs were coinjected at 5 ?g/ml
(exception being injection of Ce-phy-1 into the
C. briggsae dpy-18 strain which was at 1
?g/ml) with a dpy-7::gfp (5 ?g/ml)
5transformation marker and a pBluescript DNA
carrier in a final total DNA concentration of
120 ?g/ml, into the syncytial gonad of the
appropriate Caenorhabditis species following
published methods ( 1 7 ) .  Posit ive
transformants were isolated under
epifluorescence microscopy, maintained
clonally and assessed for phenotype rescue via
microscopy.
Transgene expression was confirmed by
RT-PCR following RNA purification and
cDNA synthesis procedures as outlined above.
phy-1  and phy-2 transgene-specific products
from both species were amplified using the
ResF primers listed above (with the exception
o f  C e - p h y - 1 R e s F ;  5 ’ -
ATGCGCCTGGCACTCCTTGTAC-3’), in
combination with the vector specific primer
T r a n s g e n e R e v  5 ’ -
GAAAACCAATGCTTAGAG-3’ from RNA
derived from the recipient dpy-18 strains and
the transformed lines.
RNA Interference - The effects of phy gene
depletion were examined using standard RNAi
injection protocols, and double-stranded RNA
for injection was produced in vitro as
described previously ( 1 7 ) . RNA was
synthesised from full-length coding sequence
corresponding to Cb-phy-1 and phy-2 genes
minus the signal peptide encoding sequence
from the  recombinant expression cloning
plasmids described above. Ten young adults of
wild type and dpy-18 (e364  and e1096) C.
elegans and wild type and dpy-18 (mf104) C.
briggsae strains were microinjected, allowed
to recover overnight, and transferred singly to
fresh plates, and their progenies scored.
Microscopy - All nematodes were viewed
either via differential interference contrast
(DIC) or epifluorescence on a Zeiss Axioskop
2 microscope and images were taken with a
Zeiss MrS digital camera and assembled in
Adobe Photoshop.
Results
Cloning of Caenorhabditis briggsae
Collagen P4H ? and ? Subunits - Analysis of
the C. briggsae database by BLAST with the
C. elegans PHY-1, PHY-2 and PDI-2
sequences revealed the presence of predicted
genes encoding the corresponding homologous
proteins. Cloning and sequencing of the
cDNAs confirmed the expression and splicing
pattern of the predicted genes, which are
available under the accession numbers
AM260973 (Cb-phy-1), AM260974 (Cb-phy-
2) and AM260975 (Cb-pdi-2). A very high
degree of amino acid sequence identity is
found between the C. briggsae and C. elegans
collagen P4H subunits (Fig. 1), that of PHY-1
and PHY-2 sequences between the two species
being 92% and 96%, respectively, and that
between the PDI-2 polypeptides being 97%.
The cysteine residues required for intrachain
disulfide bonding (4, 32) and the catalytic
residues required for binding of Fe2+ and 2-
oxoglutarate (4, 33) are all conserved (Fig. 1).
The PHY-1 polypeptides from both species
have an 18-amino-acid C-terminal extension
(Fig. 1), which is also found in the PHY-1
polypeptide of the filarial nematode
Onchocerca volvulus (34), but not in that of
Brugia malayi (31), nor in the Caenorhabditis
PHY-2 polypeptides or vertebrate and
Drosophila ? subunits (9-12, 15, 17, 30).
Generation of a C. briggsae phy-1 (dpy-
18) Mutant and Its Rescue - A C. briggsae
phy-1 mutant was isolated following a Mos1
insertion event. Like the C. elegans phy-1
(dpy-18) mutants (Fig. 2F), the C. briggsae
phy-1  mutants were shortened in length
relative to the wild type (Fig. 2A , B ), the
length reduction in both mutant species being
comparable. The C. briggsae phy-1 mutants
differed from the C. elegans dpy-18 in that the
former did not display the associated
circumferential increase (compare Fig. 2B, F).
Therefore, the phy-1 mutation in C. briggsae
causes a small (Sma) phenotype rather than the
more severe dumpy (Dpy, short and fat)
phenotype, but for consistency in
nomenclature the C. briggsae phy-1 mutants
will also be referred to as C. briggsae dpy-18.
All possible variations of gene rescue
experiments were carried out on the C. elegans
and C. briggsae dpy-18 mutants using
genomic phy-1 and phy-2 rescue constructs
containing wild type copies of the genes from
both species. The rescue constructs were co-
injected into the mutant strains with a visible
marker construct, the dpy-7::gfp cuticle
collagen. As previously reported (17) Ce-phy-
1 could completely rescue the C. elegans dpy-
18 phenotype (Table 1). In contrast, the Ce-
p h y - 1  rescue of the C. briggsae dpy-18
phenotype was only partial (Table 1) as was
Cb-phy-1 rescue of the C. briggsae dpy-18
mutant (Table 1, Fig. 2C, D). Cb-phy-1 was
however able to fully rescue C. elegans dpy-18
mutant (Table 1, Fig. 2G, H). Ce-phy-2
partially rescued the C. elegans dpy-18 mutant
(Table 1). This may be explained by the over-
expression of PHY-2 that could be expected to
produce high levels of the unusual PHY-
62/PDI-2 dimer, which is normally present only
in very low abundance (20). Ce-phy-2 could
not rescue the C. briggsae dpy-18, however,
and Cb-phy-2 failed to rescue either mutant
(Table 1). Expression of the transgenes in the
C. elegans and C. briggsae dpy-18 nematodes
was confirmed by RT-PCR using transgene-
specific primers (Fig. 2I, J). All transformed
gfp positive lines expressed the transgene (Fig.
2I, lanes 1, 3 and 5 and J, lanes 1, 3, 5 and 7),
whereas the non-transformed control
nematodes did not (Fig. 2I, lanes 2, 4 and 6
and J, lanes 2, 4, 6 and 8).
RNA Interference to Examine the
Combined Function of the Cb-phy-1 and Cb-
phy-2 Genes - The combined essential function
of Ce-phy-1 and Ce-phy-2 was previously
proven following Ce-phy-2 RNAi in a C .
elegans dpy-18 mutant background, which
resulted in an embryonic lethal (Emb)
phenotype ( 17 ) . This synthetic lethal
phenotype has been confirmed following
construction of a dpy-18/phy-2 combined
genetic mutant ( 19 ) ; Winter & Page,
unpublished observations). To address this
issue further in both species, a range of RNAi
experiments were carried out in wild type C.
elegans and C. briggsae and in the C. briggsae
dpy-18 mutants (Table 2, Fig. 3). Cb-phy-1
RNAi in the wild type C. elegans and C.
briggsae strains resulted in slight to medium
Dpy and Sma phenotypes, respectively (Table
2). Cb-phy-2 RNAi in either wild type strain
failed to produce any visible phenotype,
whereas it produced in the C. briggsae dpy-18
mutant a severe Dpy and larval arrest with
coiled larval phenotypes (Table 2, Fig. 3). Cb-
phy-1 RNAi in the C. briggsae dpy-18 mutant
background failed to increase the severity of
the dpy-18  phenotype (Table 2), thereby
supporting the premise that this is a null allele.
In direct agreement with previous Ce-pdi-2
RNAi experiments (17) , Cb-pdi-2 caused
similar severe Dpy and embryonic lethal
phenotypes irrespective of whether the RNA
was injected into a C. elegans or C. briggsae
wild type background (Table 2).
Recombinant C. briggsae PHY-2
Assembles Into a Unique Active Collagen P4H
Form with PDI-2 - The Cb-phy-1 genetic null
and RNAi results indicated similarities and
highlighted subtle differences between the
functional properties of the collagen P4Hs
assembled from the highly conserved C.
elegans and C. briggsae PHY-1, PHY-2 and
PDI-2 polypeptides. To investigate this at a
biochemical level, the recombinant C .
briggsae subunits and their collagen P4H
forms were characterized following the
infection of insect cells with viruses coding for
C. briggsae PHY-1 and PHY-2, individually
or in combination, along with C. briggsae or
C. elegans PDI-2. In control experiments
similar infections using viruses coding for the
corresponding C. elegans PHY polypeptides
were performed. The cells were harvested 72 h
after infection, homogenized in a buffer
containing 0.1% Triton X-100, and
centrifuged. The Triton X-100-soluble extracts
were analyzed by nondenaturing PAGE
followed by Western blotting with antibodies
against PHY-1 and PHY-2 (Fig. 4). P4H
activity of Triton X-100-soluble extracts was
analyzed with an assay based on the
hydroxylation-coupled decarboxylation of 2-
oxo-[1-14C]glutarate using a synthetic peptide
(Pro-Pro-Gly)10 as a substrate (Table 3). The
ability of PHY-1 to form an active dimer with
PDI-2 was shared between C. briggsae and C.
e l e g a n s  and was independent of the
Caenorhabditis source of PDI-2 (Fig. 4, lanes
1 , 2 , 5  and 6). The C. briggsae PHY-1 and
PHY-2 polypeptides were similar to those of
C. elegans in that they readily assembled into
an active PHY-1/PHY-2/(PDI-2)2 mixed
tetramer, the assembly in both cases occurring
with PDI-2 from both species (Fig. 4, lanes 9-
12 and 21-24, Table 3). Furthermore, a mixed
tetramer was also assembled when the PHY-1
and PHY-2 polypeptides were from the
different Caenorhabditis species (data not
shown). Interestingly, a C. briggsae PHY-
1/PDI-2 dimer was not detected when insect
cells expressed both C. briggsae PHY-1 and
PHY-2 together with PDI-2, although it
formed readily when only PHY-1 was present
with PDI-2 (Fig. 4, lanes 5 , 6 , 11 and 12).
Based on the recombinant expression data,
assembly of the C. briggsae PHY-1/PHY-
2/(PDI-2)2 mixed tetramer is strongly favoured
over that of the PHY-1/PDI-2 dimer.
The C. briggsae PHY-2 differed distinctly
from that of C. elegans in that a broad PHY-2
reactive band was seen when insect cells were
infected with viruses coding for C. briggsae
PHY-2 and either of the two Caenorhabditis
PDI-2 polypeptides (Fig. 4, compare lanes 19
and 20 to lanes 15 and 16). The mobility of the
complex formed by C. briggsae PHY-2 and
PDI-2 was between those of the mixed
tetramer and the PHY-1/PDI-2 dimer (Fig. 4,
compare lanes 19 and 20 to lanes 5, 6, 9, 10,
23  and 24). This indicates that C. briggsae
PHY-2, unlike that of C. elegans, can readily
7assemble into a unique soluble complex with
PDI-2. Furthermore, P4H activity assay
showed that this complex was a highly active
P4H (Table 3). The same PHY-2
immunoreactive band was present in addition
to the band corresponding to the mixed
tetramer in the samples from cells
coexpressing C. briggsae PHY-1 and PHY-2
and either PDI-2 (Fig. 4, lanes 23 and 24).
P4H activity in these samples was 2.5-3-fold
higher than in those from cells expressing only
C. briggsae PHY-2 and PDI-2, suggesting that
both enzyme forms contributed to the total
activity. Interestingly, based on the
nondenaturing PAGE analysis (Fig. 4) and
P4H activity assays (Table 3), the C. briggsae
PHY polypeptides seemed to assemble into
active PHY-1/PDI-2 dimers and PHY-1/PHY-
2/(PDI-2)2 mixed tetramers more efficiently
than their C. elegans counterparts. Based on
SDS-PAGE analysis, the expression levels of
the PHY polypeptides from both species were
equal (not shown), indicating that the more
efficient assembly of the C. briggsae PHY-1,
PHY-2 and PDI-2 to the various active
collagen P4H forms may be a true feature of
these polypeptides.
As the mobility of the novel recombinant
collagen P4H form assembled from C .
briggsae PHY-2 and PDI-2 was between those
of the mixed tetramer and the PHY-1/PDI-2
dimer, we analyzed its molecular weight by
gel filtration in a calibrated HiPrep Sephacryl
S-200 HR column. In control experiments,
either a Triton X-100-soluble extract from
insect cells coexpressing C. elegans PHY-1
and human PDI or a purified recombinant
human collagen P4H was analyzed. The P4H
assembled from C. briggsae PHY-2 and PDI-2
eluted in exactly the same position as the C.
elegans PHY-1/PHY-2/(PDI-2)2 mixed
tetramer and the human collagen P4H-I
tetramer (Fig. 5) and before the PHY-1/PDI
dimer indicating that the novel P4H form is a
(PHY-2)2(PDI-2)2 tetramer.
Comparison of the Collagen P4H Forms
Assembled in Wild Type and Mutant C.
briggsae Nematodes to the Recombinant
Forms -  The differences noted between C.
elegans and C. briggsae in the assembly of
active recombinant P4H forms were confirmed
following characterization of native extracts
prepared from wild type and dpy-18 mutant C.
briggsae worms by non-denaturing PAGE and
Western blotting. Triton X-100-soluble
extracts from insect cells co-expressing C.
briggsae PHY-1, PHY-2 and PDI-2 or PHY-1
and PDI-2 were run as controls in the same
gels. As described for C. elegans (20), PHY-
1/PHY-2/(PDI-2)2 tetramers and PHY-1/PDI-2
dimers but not PHY-2/PDI-2 dimers were
simultaneously present in native extracts from
wild type C. briggsae (Fig. 6, lanes 1 and 5).
As the recombinant expression experiments
showed that assembly of the recombinant C.
briggsae PHY-1/PHY-2/(PDI-2)2 mixed
tetramer is clearly preferred over that of the
PHY-1/PDI-2 dimer (Fig. 4, lanes 11 and 12
and Fig. 6, lane 3), the in vivo observation of
simultaneous existence of both forms may
therefore reflect a limitation in the in vitro
availability of the PHY-1 polypeptide.
As expected, the C. briggsae dpy-18
mutant was devoid of any enzyme forms
containing PHY-1 (Fig. 6, lane 2) further
confirming that it is a null mutant. This mutant
did however posses a readily identifiable
PHY-2 immunoreactive band that migrated
slower than the PHY-1/PDI-2 dimer in the
wild type but slightly faster than the mixed
tetramer (Fig. 6, compare lane 6 to lanes 1 and
5) and had a similar mobility as the band
corresponding to the recombinant (PHY-
2)2/(PDI-2)2 tetramers in insect cell
expressions (Fig. 6, compare lanes 6 and 7).
The mobility of the C. briggsae dpy-18 PHY-2
immunoreactive band differs distinctly from
that of the PHY-2/PDI-2 dimer present in C.
elegans dpy-18, the mobility of which is
identical to that of the PHY-1/PDI-2 dimer
(20) . The lack of the (PHY-2)2/(PDI-2)2
tetramers in the lysates from wild type C.
briggsae (Fig. 6, lane 5) may again reflect the
relative abundance of the PHY polypeptides in
vivo , i.e. limited availability of the PHY-2
polypeptides, and the favoured formation of
the mixed tetramer relative to the other forms.
Double Mutagenesis of the C. elegans and
C.  br iggsae PHY-1 and PHY-2
Tetratricopeptide Repeat Motifs Changes
Their Assembly Properties Towards Those of
the Other Species - A surprising result from
the aforementioned dpy-18 mutant analysis,
RNAi, rescue and recombinant expression
experiments was that the assembly properties
of the C. briggsae collagen P4H subunits are
not totally identical with those of C. elegans
despite the extremely high amino acid
sequence identity of the subunits. The major
difference between C. elegans and C. briggsae
was the ability of CbPHY-2 to efficiently form
active (PHY-2)2/(PDI-2)2 tetramers in addition
to the PHY-1/PHY-2/(PDI-2)2 tetramers and
PHY-1/PDI-2 dimers found in both species
8(Fig. 7). Furthermore, the assembly of the C.
briggsae  subunits into active P4H forms
seemed to be more efficient in general than
those of C. elegans. Comparison of the amino
acid sequences of PHY-1 and PHY-2 from the
two species indicated limited amino acid
differences (Fig. 1), the majority of which
reside in the N-terminal non-catalytic region of
the proteins. A search for protein motifs in the
PHY sequences using the InterProScan
(EMBL-EBI) (35)  indicated that the N-
terminal regions contain a tetratricopeptide
repeat (TPR)-like helical region between
residues 134-237 in PHY-1 and 144-226 in
PHY-2, with a 34-residue TPR motif between
residues 188-221 and 190-223 of the PHY-1
and PHY-2 polypeptides, respectively (Fig. 1).
An additional TPR motif was predicted to be
present in this region between PHY-1 residues
146-179 and PHY-2 residues 148-181
(personal  communicat ion,  Malcolm
Walkinshaw, University of Edinburgh). TPR
motifs mediate protein-protein and protein-
peptide interactions, and the assembly of
multiprotein complexes (36). The structure of
the peptide-substrate-binding domain of
human collagen P4H-I, comprising residues
144-244 of the 517-amino-acid ?(I) subunit,
has been recently shown to consist of two TPR
motifs and a solvating helix (37). To study
whether amino acid differences in the TPR
motifs of the C. elegans and C. briggsae PHY
polypeptides could explain the differences in
their assembly properties, site directed
mutagenesis was performed on two separate
divergent amino acids in each of the PHY-1
and PHY-2 TPR motifs to change the C .
elegans sequences to a more C. briggsae-like
sequences and vice versa, resulting in Ce-
PHY-1-T220A, Cb-PHY-1-A220T, Ce-PHY-
2-W190S and Cb-PHY-2-S190W single
mutants, and Ce-PHY-1-T220A/Q174K, Cb-
P H Y - 1 - A 2 2 0 T / K 1 7 4 Q ,  C e - P H Y - 2 -
W 1 9 0 S / V 1 7 7 N  a n d  C b - P H Y - 2 -
S190W/N177V double mutants (Fig. 1).
The mutant PHY-1 and PHY-2
polypeptides were coexpressed in insect cells
together with C. elegans or C. briggsae PDI-2
and analyzed by nondenaturing PAGE
followed by Western blotting and P4H activity
assay (Fig. 8, Table 4). The double mutant C.
elegans PHY-1 polypeptides assembled into a
dimer with PDI-2 more efficiently than the
wild type PHY-1, the increase in assembly
being 3-4-fold based on the P4H activity
obtained, while no significant increase was
obtained with the single mutant (Fig. 8A ,
Table 4). The assembly efficiency of the
double mutant C. elegans PHY-1 with PDI-2
did not reach that of wild type C. briggsae
PHY-1, however, the P4H activity obtained
being only about 28% of that of the C.
briggsae PHY-1/PDI-2 dimer (Table 4). The
double mutation in the C. briggsae PHY-1
decreased its assembly with PDI-2 by about 2-
fold relative to that of the wild type
polypeptide, despite the single mutation first
leading to an increase rather than a decrease in
the assembly and activity (Fig. 8A, Table 4).
Based on the activity assays, the assembly
efficiency of the double mutant C. briggsae
PHY-1 with PDI-2 was still about 5-fold
relative to that of C. elegans PHY-1, however
(Table 4).
The double mutant C. elegans PHY-2
assembled into a soluble complex with PDI-2
that was visible in non-denaturing PAGE after
Western blotting and had a mobility similar to
that of the complex formed by C. briggsae
PHY-2 and PDI-2 (Fig. 8B). The P4H activity
obtained with the double mutant C. elegans
PHY-2 with PDI-2 was about 8-fold relative to
that obtained with the wild type, but still only
about 11% of that obtained with C. briggsae
PHY-2 and PDI-2 (Table 4). The activity
values obtained with the single mutant C.
elegans PHY-2 with PDI-2 were between
those obtained with the wild type and double
mutant C. elegans PHY-2 with PDI-2 (Table
4). In contrast, the single and double mutations
in C. briggsae PHY-2 did not change its
assembly properties with PDI-2 (Fig. 8B), nor
had any marked effect on the resulting P4H
activity (Table 4).
The Ability of C. briggsae PHY-2 to
Assemble Into a (PHY-2)2/(PDI-2)2 Tetramer
Depends On Its N-Terminal Half - The results
obtained above indicate that the two residues
of the TPR motifs subjected to site directed
mutagenesis are involved in the assembly of
active P4H forms from the C. elegans and C.
briggsae PHY polypeptides, but differences in
these two amino acids did not fully explain the
differences observed between the assembly
properties of the subunits from the two
species. We therefore extended these studies
by replacing the N-terminal 262 amino acids
of the C. briggsae and C. elegans PHY-2
polypeptides with those from the other species.
The exchange of this N-terminal region of C.
briggsae PHY-2 with that of C. elegans PHY-
2 resulted in a dramatic loss of the ability to
form the (PHY-2)2/(PDI-2)2 tetramer (Fig. 9,
lane 3) and a 35-45-fold decrease in the P4H
9activity (Table 4). In contrast, replacement of
the N-terminal 262 amino acids of C. elegans
PHY-2 with those of C. briggsae PHY-2
resulted in efficient formation of the (PHY-
2)2/(PDI-2)2 tetramer (Fig. 9, lane 4) and an
essentially identical P4H activity relative to
that obtained with wild type C. briggsae PHY-
1 and PDI-2 (Table 4).
Discussion
The collagen P4Hs are essential enzymes
as hydroxylation of X-Pro-Gly sequences in
collagen chains is necessary for the formation
of collagen molecules with stable triple-helical
structures (2). These enzymes thus have
important implications in tissue remodelling
and as potential drug targets for the treatment
of human fibrotic diseases caused by excessive
collagen accumulation ( 3 ).  Previous
biochemical and genetic characterization of
the C. elegans cuticle collagen P4Hs indicated
that their subunit composition differed from
those described in other species, including
man (17, 20, 21). The main enzyme form in C.
elegans is a PHY-1/PHY-2/(PDI-2)2 tetramer
that contains two distinct catalytic PHY
subunits. In addition, assembly of PHY-1/PDI-
2 and PHY-2/PDI-2 dimers is possible but
much less efficient. RNA interference studies
and analysis of C. elegans strains with gene
deletions have shown that inactivation of phy-
1 and phy-2 jointly, or pdi-2 singly, leads to
embryonic lethality due to abnormal cuticle
collagen synthesis. In the present work we
have further studied the Caenorhabditis
collagen P4Hs by characterizing the
orthologous genes and encoded proteins from
the closely related free-living nematode C.
briggsae. The combined essential function of
the phy-1 and phy-2 genes was found to be a
consistent feature shared between the two
Caenorhabditis species thus supporting their
vital role in the formation of a proper
exoskeleton and in nematode survival beyond
embryogenesis. This makes these collagen
P4Hs potential novel drug targets for the
control of medically and veterinary significant
nematode species (23).
In spite of the extremely high amino acid
sequence conservation between the catalytic
PHY subunits of C. elegans and C. briggsae,
distinct differences were noted in the assembly
properties of the PHY subunits. In addition to
assembly of PHY-1/PHY-2/(PDI-2)2 tetramers
and PHY-1/PDI-2 dimers in both species, the
C. briggsae PHY-2 formed an active (PHY-
2)2/(PDI-2)2 tetramer instead of the PHY-
2/PDI-2 dimer that is formed in C. elegans.
This observation was made with both
recombinant and native C. briggsae PHY
subunits by analyzing co-expression
experiments in insect cells and protein extracts
from wild type and C. briggsae dpy-18
nematodes (Figs. 4 and 6). The subunit
composition of the active (PHY-2)2/(PDI-2)2
C. briggsae tetramer represents that commonly
present in man, insects, birds and rodents and
therefore reflects the consensus subunit
composition of animal collagen P4Hs, the
mixed tetramer and dimers being unique to
nematodes. Based on recombinant expression
experiments, assembly of the C. briggsae PHY
subunits into active P4H forms was in general
more efficient than that of the C. elegans ones,
as reflected by the amount of the different P4H
forms observed in Western blot analysis (Fig.
4) and the P4H activity generated (Table 1). It
is especially noteworthy that the C. briggsae
PHY-2 readily assembled into an active (PHY-
2)2/(PDI-2)2 tetramer in insect cell expression
experiments (Fig. 4 and Table 1). In contrast,
assembly of recombinant C. elegans PHY-2
into an active PHY-2/PDI-2 dimer is very
inefficient and the dimer is only observed at
Western blot level in C. elegans dpy-18
nematodes where its assembly is enhanced
(Fig. 4, Table 1 and (20)).
The C. elegans genome contains over 170
cuticle collagen genes, a small subset of which
results in morphological phenotypes when
mutated, an even smaller subset of these genes
being essential as evidenced by lethality
caused by their mutation (23). Although the
PHY-1/PHY-2/(PDI-2)2 mixed tetramer is the
major cuticle collagen P4H in the two
Caenorhabditis  species, both species can
survive normally in the absence of PHY-2, as
assessed by the RNAi depletion experiments
(Fig. 2 and (17)) and by the deletion of the C.
elegans phy-2 gene (19). The C. elegans phy-2
null deletion mutants can compensate for the
lack of the mixed tetramer by markedly
increasing the assembly of the PHY-1/PDI-2
dimer resulting in retention of 54-57% of the
P4H activity (20) and 64% of the 4-
hydroxyproline content (19) relative to the
wild type, these values being sufficient to
maintain a wild type appearance. A similar
compensation mechanism is likely to exist in
C. briggsae  as recombinant expression
experiments showed that the C. briggsae
PHY-1 subunit can also assemble into an
active dimer with PDI-2. Furthermore, as lack
of PHY-2 has no effect on cuticle synthesis, it
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can be deduced that the major collagen P4Hs
of wild type Caenorhabditis nematodes, the
PHY-1/PHY-2/(PDI-2)2 tetramers, and the
PHY-1/PDI dimers present in phy-2 mutant
nematodes have identical substrate
specificities.
Unlike the lack of PHY-2, lack of PHY-1
affects the cuticular extracellular matrix and
leads to a deformed body shape in both
Caenorhabditis species as indicated by the
RNAi experiments and by the characterization
of phy-1 null mutants (Fig. 2, (17, 19, 20)).
The resulting phy-1 mutant phenotypes were
not exactly identical, however, being small
(Sma) in C. briggsae and a combination of
small and fat (Dpy) in C. elegans (Fig. 2). The
nematode cuticle has two distinct regions,
namely those derived from the lateral
hypodermal seam cells and the dorso-ventral
hypodermis (38, 39). The structural properties
of the two regions differ and mutations in
individual collagen genes can affect one or
both of these regions and impart distinct
region-specific phenotypes (39) . It can be
extrapolated that the Sma phenotype is less
severe than the Dpy phenotype and is a result
of milder disruption affecting only the lateral
cuticle structures. The Dpy phenotype, on the
other hand, has a more global affect due to
disruption of both the lateral and the
circumferential dorso-ventral cuticle. The less
severe phenotype in the phy-1  mutant C.
b r i g g s a e  may reflect the fact that the
remaining PHY-2 isoform can readily
assemble into an active (PHY-2)2(PDI-2)2
tetramer as evidenced by recombinant
coexpression studies (Fig. 4 and Table 3),
while the corresponding C. elegans subunits
associate into a PHY-2/PDI-2 dimer much less
efficiently (Fig. 4 and Table 3), the remaining
P4H activity in phy-1 mutant C. elegans
nematodes being only 0.7-2.5% relative to the
wild type (20). It is also possible that the
substrate specificities of the C. briggsae
(PHY-2)2(PDI-2)2 tetramers and C. elegans
PHY-2/PDI-2 dimers are not identical and they
may therefore modify different subsets of the
cuticle collagens, which in turn are
incorporated into the two structurally distinct
regions of the cuticle.
The orthologous nature of the C. elegans
and C. briggsae phy-1 and phy-2 genes was
studied here by detailed analysis of dpy-18
(phy-1) mutants of both species and the ability
of intra-species and inter-species phy-1 and
phy-2 genes to rescue the associated body
morphology defects. As expected, the
complementation experiments revealed that
the phy-1 transgenes from the same species
were able to rescue the corresponding mutant
phenotypes, namely Ce-phy-1 can rescue Ce-
dpy-18 and Cb-phy-1 can partially rescue Cb-
dpy-18. In addition, the phy-1 genomic rescue
constructs were able to completely or partially
rescue the mutant phenotype of the other
species and thus showed that the encoded
polypeptides are highly similar in their
structural and functional properties. The
reason why only partial rescue was obtained
by injection of Ce-phy-1 into Cb-dpy-18 may
be attributed to the fact that this construct was
toxic at the standard injection concentration
and was subsequently introduced at a five-fold
lower concentration. Although expression of
the transgene was detected in the partially
rescued lines (Fig. 2J), its expression level
may have been lower than that of the
endogenous gene in wild type C. briggsae.
The partial rescue of Ce-dpy-18 by a Ce-phy-2
transgene was unexpected, as no rescue has
been obtained in previous attempts (Winter
and Page, unpublished observations). This
may be explained by the use of genomic phy-2
rescue constructs in the current experiments
instead of cDNA-derived constructs used in
the previous studies. The most likely
explanation for the partial rescue of Ce-dpy-18
by a Ce-phy-2 transgene is a further increase in
the amount of the PHY-2/PDI-2 dimer. The
lack of rescue in the remaining experiments,
namely that of Ce-dpy-18 with Cb-phy-2 and
Cb-dpy-18 with C. briggsae or C. elegans phy-
2, should be taken as an indication rather than
a conclusive lack of compensation in spite of
the fact that RT-PCR controls confirmed the
expression of the transgenes.  It is important to
note that all C. briggsae rescue constructs
were made as a fusion to the C. elegans phy-1
promoter and 3? UTR regulatory sequences
and this may have exceeded the limits of the
transgenic complementation system, a point
supported by the fact that the Cb-phy -1
completely rescued the Ce-dpy-18 mutant but
only partially rescued by the Cb-dpy-18
mutant.  In the case of the phy-2 experiments,
lack of rescue may also be compounded by
differences in expression levels or the
temporal control of expression relative to the
endogeneous genes. Lack of inter-species phy-
2 rescue may also be a true phenomenon,
however, and reflect differences in substrate
specificities and/or assembly efficiencies of
the P4H forms that contain only PHY-2 as the
catalytic subunit.
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The fact that despite the extremely high
amino acid sequence identity between the C.
briggsae and C. elegans PHY-2 polypeptides,
they assembled with PDI into different active
P4H forms when no PHY-1 was present, i.e.
tetramers and dimers, respectively, enabled us
to identify the regions of the PHY-2
polypeptides that are responsible for this
difference. Motif searches identified two TPR-
like domains between residues 148-223 of the
PHY-2 polypeptides. TPR motifs are involved
in many protein-protein interactions and
assembly of multi-protein complexes (36) and
indeed, a 2.3Å crystal structure of the peptide-
substrate-binding domain of the ?(I) subunit
of human type I collagen P4H has shown that
it is a TPR domain with functionally important
aromatic residues (37). Site-directed
mutagenesis was therefore applied to
determine the effect of two amino acid
differences between the C. briggsae and C.
elegans PHY-2 TPR domains on the assembly
properties of the full-length polypeptides.
Double mutagenesis of the C. elegans and C.
briggsae PHY-2 TPR motifs changed their
assembly properties towards that of the other
species but did not lead to a complete reversal,
which was achieved only after the entire N-
terminal halves of the polypeptides were
swapped. These results indicate that although
the identified TPR residues are important in
determining the assembly properties of a PHY-
2 polypeptide with PDI-2, other adjacent
residues in the N-terminal half also play a vital
role. Previous domain swap experiments have
shown that residues Gln121-Ala271 and Asp1-
Leu122 of C. elegans PHY-1 and PHY-2,
respectively, are critical for the assembly of
the mixed PHY-1/PHY-2/(PDI-2)2 tetramer
(20). The current study further emphasizes the
importance of the N-terminal non-catalytic
half of the PHY polypeptides in dictating their
assembly properties.
It is interesting to note that the other
available PHY-2 sequence, from the closely
related C a e n o r h a b d i t i s  r a m a n e i
(wormbase.org; and Winter and Page,
unpublished results), is 97.5% and 94.5%
identical to the C. briggsae and to C. elegans
sequences, respectively. In addition, the
aforementioned two crucial amino acids of the
TPR domain shown to be involved in active
(PHY-2)2(PDI-2)2  formation are completely
conserved between C. briggsae and C .
ramanei, whereas these amino acids from the
Brugia malayi (31) and Onchocerca volvulus
(34) PHY sequences differ from all three
Caenorhabditis species. It may be proposed
that the presence of two phy genes (phy-1 and
phy-2) results in partial redundancy, thereby
making them less-sensitive to mutation and
ultimately allowing for the evolution of their
respective roles and the wide range of active
complexes that they form.
The results presented in this study
reinforce the findings that cuticle collagen
P4Hs are essential for the survival of
nematode species, but also emphasize the fact
that the assembly efficiency of active P4H
forms and even their molecular composition
can differ between two closely related species
despite extremely high amino acid sequence
identity of the enzyme subunits. Therefore, as
shown here, mutation of genes that are highly
conserved between two species may not
necessarily have identical phenotypic
consequences. The existence of unique
collagen P4H forms in nematodes, PHY-
1/PHY-2/(PDI-2)2 and (PHY-2)2/(PDI-2)2
tetramers and PHY-1/PDI-2 and PHY-2/PDI-2
dimers in the Caenorhabditis species and even
active (PHY-1)4 tetramers lacking a PDI/?
subunit in Brugia malayi (31) will help to
elucidate the assembly process of collagen
P4Hs in general.
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 Footnote
The gene sequences described in this paper have been deposited in the public databases under
accession numbers, AM260973 (Cb-phy-1), AM260974 (Cb-phy-2) and AM260975 (Cb-pdi-2). 
Figure Legends
FIGURE 1. Amino acid alignment of the C. briggsae (Cb  prefix) PHY-1 (GenBank no.
AM260973) and PHY-2 (GenBank no. AM260974) with C. elegans (Ce prefix) PHY-1 (GenBank
no. Z81134) and PHY-2 (GenBank no. Z69637). Numbering starts from the mature polypeptides
from which the signal peptide sequences have been removed. Gaps (dashes) were introduced for
maximal alignment. The cysteine residues required for intrachain disulfide binding and the histidine,
aspartic acid and lysine residues required for binding of Fe2+ and 2-oxoglutarate at the catalytic site
are indicated with an asterisk. The predicted TPR motifs are indicated by an inverted L. The sites of
the point mutations introduced into the TPR motifs are indicated by a black downward arrow in the
PHY-1 and a grey downward arrow in the PHY-2 sequences and the site of exchange to generate
inter-species hybrid PHY-1 and PHY-2 polypeptides are indicated by an upward arrow.
FIGURE 2. The C. briggsae phy-1 (dpy-18) mutant and rescue of the C. briggsae and C. elegans
dpy-18 strains. A-C and E-F, Nomarski images of adult hermaphrodites. A, Wild type C. briggsae
(length approximately 1050 µm). B, Cb-dpy-18 (mf104) (length approximately 670 µm). C, Partial
rescue of Cb-dpy-18 (mf104) by injection of a wild type copy of Cb-phy-1. The two uppermost
nematodes are rescued (lengths approximately 920 and 930 µm) relative to the non-rescued nematode
below (length approximately 720 µm). D , Epifluorescence image of the nematodes shown in C,
depicting expression of GFP from the co-injected selectable marker dpy-7::gfp in the rescued
nematodes, but missing it in the non-rescued one. E, Wild type C. elegans (length approximately 1000
µm). F, Ce-dpy-18 (e1096) (length approximately 700 µm). G, Rescue of Ce-dpy-18 (e1096) by
injection of a wild type copy of Cb-phy-1 (length approximately 1050 µm). H, Epifluorescence image
of the rescued nematode shown in G, depicting expression of GFP from the co-injected selectable
marker dpy-7::gfp. Scale bars, 100 µm. I and J, RT-PCR confirmation of transgene expression. I,
Transgene expression in transformed (lanes 1, 3 and 5) and non-transformed (lanes 2, 4 and 6) Ce-
dpy-18. J, Transgene expression in transformed (lanes 1, 3, 5 and 7) and non-transformed (lanes 2, 4,
6 and 8) Cb-dpy-18. The transgene expressed is denoted above individual lanes. The sizes of the
products, approximately 1.6 kb, confirm that the amplification was derived exclusively from the
spliced transgenic messages.
FIGURE 3. The effect of RNAi of phy-2 in C. briggsae dpy-18 (mf104) mutant background.
Double-stranded RNA corresponding to the C. briggsae phy-2 coding sequence was injected to the C.
briggsae dpy-18 nematodes and the phenotypes of the progeny were analyzed. A, Newly hatched first
stage larva (L1) displaying severe Dpy and coiling phentoypes. B, Typical severe Dpy L1 larvae
displaying a larval arrest phenotype. Scale bar, 50 µm.
FIGURE 4. Analysis of P4H forms assembled from recombinant C. briggsae P4H subunits.
Recombinant C. briggsae PHY-1 and PHY-2 were coexpressed in insect cells together with C.
briggsae or C. elegans PDI-2 polypeptides. The corresponding C. elegans PHY polypeptides were
expressed in control experiments. The cells were harvested 72 h after infection, homogenized in a
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Triton X-100-containing buffer, and centrifuged. The Triton X-100-soluble fractions were analyzed
by nondenaturing PAGE followed by Western blotting using antibodies against PHY-1 (top panel)
and PHY-2 (bottom panel). The positions of the P4H tetramers (T) and dimers (D) are indicated by
arrows.
FIGURE 5. Gel filtration analysis of a Triton X-100-soluble fraction from insect cells expressing
recombinant C. briggsae PHY-2 and PDI-2. A Triton X-100-soluble fraction from insect cells
expressing recombinant C. briggsae PHY-2 and PDI-2 was applied to a Superdex 200 column, and
the eluted fractions were assayed for P4H activity (— ? —). In control experiments, a Triton X-100-
soluble fraction from insect cells expressing recombinant C. elegans PHY-1 and human PDI-2 and
purified recombinant human type I collagen P4H were applied to the column, and the fractions were
assayed for P4H activity (— ?—) and absorbance at 280 nm (--- ?---), respectively.
FIGURE 6. Analysis of P4H forms in wild type and dpy-18 C. briggsae in vivo. Nematodes from
the wild type (lanes 1 and 5) and dpy-18 (mf104) (lanes 2 and 6 ) C. briggsae strains were
homogenized in a buffer containing Triton X-100, and the soluble fractions were analyzed by non-
denaturing PAGE followed by Western blotting using antibodies against PHY-1 (A) and PHY-2 (B).
Triton X-100-soluble proteins from insect cells coexpressing C. briggsae PHY-1, PHY-2 and PDI-2
were used as a control in A and B (lanes 3 and 7) and PHY-1 and PDI-2 in panel A  (lane 4). The
positions of the PHY-1/PHY-2/(PDI-2)2 and (PHY-2)2/(PDI-2)2 tetramers and PHY-1/PDI-2 dimers
are indicated by arrows.
FIGURE 7. Schematic representation of the P4H forms present in wild type and mutant C.
briggsae and C. elegans strains. The PHY-1/PHY-2/(PDI-2)2 mixed tetramers and PHY-1/PDI-2
dimers are present in both wild type C. briggsae and C. elegans. In the absence of the PHY-1
polypeptide, a (PHY-2)2/(PDI-2)2 tetramer is assembled in C. briggsae dpy-18, while a PHY-2/PDI-2
dimer is found in the C. elegans dpy-18. When the PHY-2 polypeptide is lacking, a PHY-1/PDI-2
dimer is still present and the assembly of this dimer has been previously shown to be markedly
increased in C. elegans relative to the wild type (20). When both PHY-1 and PHY-2 are lacking, no
active collagen P4H is formed in either species.
FIGURE 8. Effect of point mutations in the TPR motifs of C. briggsae and C. elegans PHY-1 and
PHY-2 on their assembly properties with PDI-2. Two point mutations were introduced into the
TPR motifs of the Caenorhabditis PHY polypeptides by site directed mutagenesis to convert these
residues to ones present in the other species. The double mutant (DM) Ce-PHY-1-T220A/Q147K, Cb-
PHY-1-A220T/K174Q, Ce-PHY-2-W190S/V177N and Cb-PHY-2-S190W/N177V, and the wild type
PHY-1 and PHY-2 from both species were expressed in insect cells together with PDI-2, and the cells
were harvested and homogenized as described in the legend to Fig. 4. Triton X-100-soluble fractions
were analyzed by non-denaturing PAGE followed by Western blotting using antibodies against PHY-
1 (A) and PHY-2 (B). The positions of the (PHY-2)2/(PDI-2)2 tetramers (T) and PHY-1/PDI-2 dimers
(D) are indicated by arrows.
FIGURE 9. Analysis of tetramer formation by inter-species hybrid Caenorhabditis PHY-2
polypeptides with PDI-2. Hybrid PHY-2 polypeptides in which the N-terminal 262 amino acids were
changed between C. elegans and C. briggsae, named CeN/CbC-PHY-2 and CbN/CeC-PHY-2, and
wild type PHY-2 from both species were expressed in insect cells together with PDI-2. The cells were
harvested and homogenized as described in the legend to Fig. 4, and Triton X-100-soluble fractions
were analyzed by non-denaturing PAGE followed by Western blotting using an antibody against
PHY-2. The position of the (PHY-2)2/(PDI-2)2 tetramers (T) is indicated by an arrow.
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TABLE 1
Rescue experiments of C. elegans and C. briggsae dpy-18 phenotype by injection of wild
type phy-1 and phy-2 genomic constructs from both species
Genomic rescue
clone injected
Recipient Strain Outcome
Ce-phy-1 C. elegans dpy-18 (e364 & e1096) Rescue
Ce-phy-2 C. elegans dpy-18 (e364) Partial Rescue
Cb-phy-1 C. elegans dpy-18 (e1096) Rescue
Cb-phy-2 C. elegans dpy-18 (e1096 & e364) No Rescue
Cb-phy-1 C. briggsae dpy-18 (mf104) Partial Rescue
Cb-phy-2 C. briggsae dpy-18 (mf104) No Rescue
Ce-phy-1 C. briggsae dpy-18 (mf104) Partial Rescue
Ce-phy-2 C. briggsae dpy-18 (mf104) No Rescue
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TABLE 2
Effect of double-stranded RNA interference of C. briggsae phy-1, phy-2 and pdi-2 in wild
type C. elegans and C. briggsae and C. briggsae dpy-18
RNAi construct
injected
Effect on Caenorhabditis strains
Wild type C. elegans Wild type C. briggsae C. briggsae dpy-18
Cb-phy-1 Slight/medium Dpy Slight Dpy/ Sma Slight Dpy/ Sma
Cb-phy-2 Wild type Wild type Severe Dpy/ Lva
Cb-pdi-2 Severe Dpy/Emb Severe Dpy/Emb ND
Dpy, dumpy; Sma, small; Lva, larval lethal; Emb, embryonic lethal; ND, not determined.
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TABLE 3
Collagen P4H activity in Triton X-100 extracts of insect cells expressing recombinant C.
elegans (prefix Ce) and C. briggsae (prefix Cb) PHY-1, PHY-2 and PDI-2 polypeptides in
various combinations.
Values are given in dpm/100?g of extractable cell protein, mean ± S.D. from 4-6 independent
experiments.
Polypeptides expressed Collagen P4H activity
dpm/100 µg
CePHY-1 + CePDI-2    780 ± 130
CePHY-1 + CbPDI-2  1230 ± 140
CePHY-2 + CePDI-2    190 ± 130
CePHY-2 + CbPDI-2  250 ± 90
CbPHY-1 + CePDI-2    5570 ± 1990
CbPHY-1 + CbPDI-2 20,340 ± 2420
CbPHY-2 + CePDI-2 31,900 ± 9150
CbPHY-2 + CbPDI-2 30,570 ± 4280
CePHY-1 + CePHY-2 + CePDI-2           35,550 ± 1260
CePHY-1 + CePHY-2 + CbPDI-2 21,920 ± 1910
CbPHY-1 + CbPHY-2 + CePDI-2    92,700 ± 18,850
CbPHY-1 + CbPHY-2 + CbPDI-2 80,720 ± 5120
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Table 4
Collagen P4H activity in Triton X-100 extracts of insect cells expressing recombinant C.
elegans (prefix Ce) and C. briggsae (prefix Cb) PHY-1 and PHY-2 polypeptides with point
mutations in the TPR motifs, and inter-species hybrid PHY-2 polypeptides with PDI-2.
Values are given in dpm/100?g of extractable cell protein, mean ± S.D. from 3-6 independent
experiments.
Polypeptides expressed Activity
dpm/100 µg
CePHY-1 + CePDI-2    1750 ± 370
CePHY-1-T220A + CePDI-2    2100 ± 230
CePHY-1- Q147K/T220A + CePDI-2    5640 ± 300
CePHY-2 + CePDI-2      520 ± 160
CePHY-2-W190S + CePDI-2  2130 ± 60
CePHY -2- V177N/W190S + CePDI-2    4040 ± 260
CbPHY-1 + CbPDI-2   19,830 ± 1820
CbPHY-1-A220T + CbPDI-2   32,520 ± 3940
CbPHY-1-K174Q/A220T + CbPDI-2    9370 ± 900
CbPHY-2 + CbPDI-2   35,850 ± 3410
CbPHY-2-S190W + CbPDI-2   26,070 ± 3900
CbPHY-2-N177V/S190W + CbPDI-2   30,990 ± 5030
CeN/CbCPHY-2+ CePDI-2 or CbPDI-2      780 ± 130
CbN/CeCPHY-2+ CePDI-2 or CbPDI-2   38,935 ± 8482
CePHY-1 + CePHY-2 + CePDI-2   30,840 ± 2690
CbPHY-1 + CbPHY-2 + CbPDI-2 101,930 ± 5620
Figure 1 
 
CbPHY-1    1 DLFTSIADMQQLLETERNIPKLLDKYIHEEEERLVQLKKLSEEYSKKNEQSIANGMNDIV 
CePHY-1    1 DLFTSIADMQNLLETERNIPKILDKYIHDEEERLVQLKKLSEEYSKKNEISIENGLKDIT 
CbPHY-2    1 DLFTAIADLQHMLGAEKDVTTVIDQYIAAERARLDDLRRYAHEYVHRNAHAEAVGPEFVT 
CePHY-2    1 DLFTAIADLQHMLGAEKDVTTIIDQYIEAERARLDDLRRYAHEYVHRNAHAESVGPEFVT 
 
 
CbPHY-1   61 NPINAFLLIKRKIFDWKEIESKMNANKAGIHVSSITDDNYG--VRYPTADDLSGAAIGLL 
CePHY-1   61 NPINAFLLIKRKIFDWKEIESKMNANKAGNVVSSITDDSYG--VRYPTADDLSGAAIGLL 
CbPHY-2   61 NPINAYLLIKRLTSEWKKVENIMLNNKATTFLKNITDNRVRSEVKFPGEEDLSGAAIALL 
CePHY-2   61 NPINAYLLIKRLTTEWKKVENIMLNNKASTFLKNITDNRVRSEVKFPGEEDLSGAATALL 
 
 
CbPHY-1  119 RLQDTYRLDTKDLADGKIYQDQGNYTFSAKDCFEIARAAYNEHDFYHTVMWMEEAKRRMD 
CePHY-1  119 RLQDTYRLDTKDLADGKIYADQGNYTFSAKDCFEIARAAYNEHDFYHTVMWMEEAQRRLG 
CbPHY-2  121 RLQDTYKLDTLDLSNGIIGGEKVSNKLSGHDTFEVGRAAYNQKDYYHCLMWMQVALNKIE 
CePHY-2  121 RLQDTYSLDTLDLSNGIIGGEKVSNKLSGHDTFEVGRSAYNQKDYYHCLMWMQVALVKIE 
 
 
CbPHY-1  179 DEEEPTADMEDILEYLAFALYKQNNLKHALKLTDELYKMNPAHPRAKGNIKWYEDLLEQE 
CePHY-1  179 DEVEPTVEVEDILEYLAFALYKQNNLKHALKLTEELYKMNPTHPRAKGNVKWYEDLLEQE 
CbPHY-2  181 NESPPSVEESEILEYLAYSLYQQGNVRRALSLTKRLAKIAPNHPRAKGNVKWYEDMLQGK 
CePHY-2  181 NENPPTIEEWEILEYLAYSLYQQGNVRRALSLTKRLAKIAPNHPRAKGNVKWYEDMLQGK 
 
                                               *                * 
CbPHY-1  239 GVRRSEMRKSIPPIQNRRPDSVLGNTERTMYEALCRNEVP-VSQKDISKLYCYYKRDRPF 
CePHY-1  239 GVRRSDMRKNLPPIQNRRPDSVLGNTERTMYEALCRNEVP-VSQKDISRLYCYYKRDRPF 
CbPHY-2  241 -----DMVGDLPPIVNKR-VEFDGIVERDAYEALCRGEIPPVEEKWKSKLRCYLKRDKPF 
CePHY-2  241 -----DMVGDLPPIVNKR-VEYDGIVERDAYEALCRGEIPPVEPKWKNKLRCYLKRDKPF 
 
 
CbPHY-1  298 LIYAPIKVEIKRFNPLAVLFKDVISDEEVATIQELAKPKLARATVHDSVTGKLVTATYRI 
CePHY-1  298 LVYAPIKVEIKRFNPLAVLFKDVISDDEVAAIQELAKPKLARATVHDSVTGKLVTATYRI 
CbPHY-2  295 LKIAPIKVEILRFDPLAVLFKNVISDSEIEVIKELASPKLKRATVQNSKTGELEHATYRI 
CePHY-2  295 LKLAPIKVEILRFDPLAVLFKNVIHDSEIEVIKELASPKLKRATVQNSKTGELEHATYRI 
 
 
CbPHY-1  358 SKSAWLKAWEHEVVERVNKRIDLMTNLEMETAEELQIANYGIGGHYDPHFDHAKKEESKS 
CePHY-1  358 SKSAWLKEWEGDVVETVNKRIGYMTNLEMETAEELQIANYGIGGHYDPHFDHAKKEESKS 
CbPHY-2  355 SKSAWLKGDLDPVIDRVNRRIEDFTGLNQATSEELQVANYGLGGHYDPHFDFARKEEKNA 
CePHY-2  355 SKSAWLKGDLDPVIDRVNRRIEDFTNLNQATSEELQVANYGLGGHYDPHFDFARKEEKNA 
 
                                                                        * 
CbPHY-1  418 FESLGTGNRIATVLFYMSQPSHGGGTVFTEVKSTVLPTKNDALFWYNLYKQGDGNPDTRH 
CePHY-1  418 FESLGTGNRIATVLFYMSQPSHGGGTVFTEAKSTILPTKNDALFWYNLYKQGDGNPDTRH 
CbPHY-2  415 FKTLNTGNRIATVLFYMSQPERGGATVFNHLGTAVFPSKNDALFWYNLRRDGEGDLRTRH 
CePHY-2  415 FKTLNTGNRIATVLFYMSQPERGGATVFNHLGTAVFPSKNDALFWYNLRRDGEGDLRTRH 
 
               *           *            * 
CbPHY-1  478 AACPVLVGIKWVSNKWIHEKGNEFRRPCGLKSSDKERFVGDLG-IGPEPRDAPNLSPNLG 
CePHY-1  478 AACPVLVGIKWVSNKWIHEKGNEFRRPCGLKSSDYERFVGDLG-YGPEPRNAPNVSPNLA 
CbPHY-2  475 AACPVLLGVKWVSNKWIHERGQEFTRPCGLEEGVQENFIGDLSPYANDP----------- 
CePHY-2  475 AACPVLLGVKWVSNKWIHEKGQEFTRPCGLEEEVQENFIGDLSPYANDP----------- 
 
 
CbPHY-1  537 KDVWETI 
CePHY-1  537 KDVWETL 
CbPHY-2      ------- 
CePHY-2      ------- 
 
 
 
 
 
 
 
 
 








